Verrica Pharmaceuticals Inc.

VRCA· Nasdaq

Since Oct 4, 2025

Transactions: 12
Purchases: 12
Sales: 0
Purchase value: $18.18M
Sale value: $0.00

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Rosenberg Noah L.CMO

Filed Aug 18, 2026Period of report Aug 17, 20260001579649-26-000005

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
PurchaseAug 18, 2026	Common Stock^F1	2,030	$4.92	$9.99K	8,587	Direct
PurchaseAug 17, 2026	Common Stock^F1	4,200	$4.91	$20.62K	6,557	Direct

Filing footnotes · 1

F1The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.90 to $4.95 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Open on SEC EDGAR

Kirby John J.Interim CFO

Filed Aug 18, 2026Period of report Aug 18, 20260001556327-26-000003

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
PurchaseAug 18, 2026	Common Stock^F1	5,000	$4.93	$24.65K	23,962	Direct

Zawitz DavidChief Operating Officer

Filed Aug 18, 2026Period of report Aug 17, 20260002046750-26-000004

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
PurchaseAug 17, 2026	Common Stock^F1	6,000	$4.98	$29.88K	27,000	Direct

Rieger JaysonDirector · CEO and President

Filed Aug 18, 2026Period of report Aug 14, 20260002043558-26-000005

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
PurchaseAug 17, 2026	Common Stock	5,000	$4.91	$24.55K	207,593	Direct

Zawitz DavidChief Operating Officer

Filed Nov 25, 2025Period of report Nov 25, 20250002046750-25-000004

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
PurchaseNov 25, 2025	Common Stock^F1	10,000	$4.2425	$42.43K	21,000	Direct

Rieger JaysonDirector · CEO and President

Filed Nov 25, 2025Period of report Nov 25, 20250002043558-25-000003

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
PurchaseNov 25, 2025	Common Stock^F1	94,311	$4.2425	$400.11K	182,593	Direct

Rosenberg Noah L.CMO

Filed Nov 25, 2025Period of report Nov 25, 20250001579649-25-000004

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
PurchaseNov 25, 2025	Common Stock	2,357	$4.2425	$10.00K	2,357	Direct

Kirby John J.Interim CFO

Filed Nov 25, 2025Period of report Nov 25, 20250001556327-25-000004

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
PurchaseNov 25, 2025	Common Stock^F1	3,536	$4.2425	$15.00K	8,962	Direct

Manning Paul BDirector · 10% owner

Filed Nov 25, 2025Period of report Nov 25, 20250001494695-25-000004

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
PurchaseNov 25, 2025	Common Stock^F1^F2	1,375,380	$4.2425	$5.84M	3,958,189

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.

Filing footnotes · 9

F1Effective July 24, 2025, the Issuer effected a 1-for-10 reverse stock split of the Issuer's common stock. The number of securities reported herein have been adjusted to reflect the reverse stock split.
F2The shares are held by Mr. Manning jointly with his spouse.
F3The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of the manager of BKB and has shared voting and investment power with respect to the shares held by BKB.
F4These shares are held in separate trusts for the benefit of the Reporting Person's immediate family members. The Reporting Person's spouse is trustee of each trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F5The shares are held directly by The Paul B. Manning Revocable Trust dated May 10, 2000 (the "Trust"). The Reporting Person is the trustee of the Trust and has sole voting and investment power with respect to the shares held by the Trust.
F6The shares are held directly by PBM Capital Investments, LLC ("PBMCI"). The Reporting Person is CEO of PBMCI and has sole voting and investment power with respect to the shares held by PBMCI.
F7Immediately exercisable.
F8The reported securities are included within 1,375,380 investment units purchased by the Reporting Person for $4.2425 per investment unit. Each investment unit consists of one share of Common Stock and a Series C warrant for one fourth of a share of common stock. The Reporting Person will not be entitled to exercise any portion of a Series C Warrant that, upon giving effect to such exercise, would cause the aggregate number of shares beneficially owned by the Reporting Person to exceed 49.99% of the number of shares of the Issuer's common stock outstanding immediately after giving effect to the exercise.
F9The reported securities are included within 2,750,762 investment units purchased by the Reporting Person for $4.2425 per investment unit. Each investment unit consists of one share of Common Stock and a Series C warrant for one fourth of a share of common stock. The Reporting Person will not be entitled to exercise any portion of a Series C Warrant that, upon giving effect to such exercise, would cause the aggregate number of shares beneficially owned by the Reporting Person to exceed 49.99% of the number of shares of the Issuer's common stock outstanding immediately after giving effect to the exercise.